Developer docs
API playgroundTry for free, no card

Search company profiles

Greenphire

Full company profile

uuid0003w8k

Namestring
Greenphire
Legal namestring
Greenphire LLC
Websiteurl
greenphire.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Greenphire, founded in 2007 and headquartered near Philadelphia, Pennsylvania, built its business around clinical trial patient payments and travel logistics for pharmaceutical sponsors, contract research organizations (CROs), and clinical trial research sites. In February 2024, Greenphire acquired Clincierge to extend its concierge travel and patient support capabilities, and in 2025 the company merged with Suvoda to form a unified clinical trial technology platform. Following the merger, Greenphire Patient Payments and Greenphire Travel continue as branded product lines within the Suvoda platform, which now spans interactive response technology (RTSM/IRT), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), scheduling, site payments, and budgeting and benchmarking. The combined platform reports 6,000+ trials conducted across 115+ countries and a 34% share of trials that received FDA approval since 2024, with roughly 65% of trials concentrated in oncology, rare disease, and CNS indications.

The technology stack follows a platform-plus-modules architecture centered on RTSM/IRT, augmented by eCOA, eConsent, site payments, and budgeting modules. Recent investment has focused on AI: Sofia, an AI assistant deployed within the IRT platform to reduce administrative burden on study teams, and an agentic RTSM capability that the company positions as enabling deployment from kickoff to user acceptance testing in as little as two weeks. A unified patient-facing mobile application consolidates scheduling, questionnaires, travel details, receipt submission, and reimbursement tracking into a single interface, addressing a well-documented fragmentation problem in trial participant experience. The technology is backed by five granted platform architecture patents and has been recognized externally, including a consecutive-year Leader designation in Everest Group's 2025 RTSM PEAK Matrix and a 2026 MedTech Breakthrough award for the Patient App.

Greenphire operates an enterprise SaaS business model: revenue is generated through multi-year subscription licensing of the platform and its modules to pharmaceutical sponsors and CROs, with quote-based pricing initiated via a 'Request a Demo' engagement model. Distribution is exclusively direct enterprise field sales, supported by a content-led demand generation funnel (blog, The ClinTech Podcast, webinars, case studies, industry events) and a dedicated CRO partnership program. The company has no public pricing and no self-serve channel, consistent with regulated, mission-critical enterprise software economics in life sciences.

Short descriptiontext

Greenphire provides patient payment and travel logistics technology for clinical trials, serving pharmaceutical sponsors, CROs, and research sites globally. Following its 2025 merger with Suvoda, it operates within a unified clinical trial technology platform spanning RTSM, eCOA, patient apps, and AI-enabled workflows.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKing Of Prussia, United States
HQ citystring
King Of Prussia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial software, patient payment solutions, clinical trial travel, RTSM IRT platforms, eCOA eConsent
Industry3 codes
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code4 codes
  • Computer Systems Design and Related Services5415
  • Computer Systems Design Services541512
  • Other Computer Related Services541519
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
  • Services-Health Services8000
Product category
Clinical Trial Technology Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise SaaS Platform Subscriptions
TypeSubscription Recurring
Description

Subscription-based licensing of the clinical trial technology platform (RTSM/IRT, eCOA, eConsent, patient payments, travel, scheduling, site payments) to pharmaceutical sponsors and CROs. Enterprise agreements with pharmaceutical companies and CROs, consistent with multi-year contractual subscriptions.

suvoda.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise subscription pricing for pharmaceutical sponsors and CROs
ModelSubscriptionBilling cadenceMulti-year contract
Notes

No public pricing tiers listed. Sales engagement is via 'Request a Demo' and direct contact, indicating quote-based enterprise pricing.

suvoda.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Greenphire Patient Payments
Description

Patient payment solution for clinical trials

suvoda.com
+1 more record
Core offering1 text field

Greenphire provides a clinical trial technology platform focused on patient payments, reimbursement management, and concierge travel and logistics support for clinical trial participants. Following its 2025 merger with Suvoda, the offering is delivered as part of a unified platform covering RTSM/IRT, eCOA, eConsent, patient payments, patient travel, scheduling, and site payments sold via enterprise SaaS subscriptions to pharmaceutical sponsors and CROs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 6,000+ clinical trials conducted on the platform, with 65% in oncology, rare disease, and CNS
+4 more records
Product overview1 text field

Greenphire operates as part of the unified Suvoda clinical trial technology platform following the 2025 merger. The platform follows a platform-plus-modules architecture centered on RTSM (Interactive Response Technology) as the core product, augmented by eCOA and eConsent modules for data collection and compliance. Patient-facing solutions include the Greenphire Patient Payments and Greenphire Patient Travel products (acquired brands now integrated into the platform), alongside a unified Patient App that consolidates scheduling, questionnaires, travel details, and payment management. Supporting modules cover Site Payments and Budgeting & Benchmarking. The platform serves pharmaceutical sponsors and CROs across 115+ countries, with over 6,000 trials conducted including 65% in oncology, rare disease, and CNS.

Product and service3 records
1Greenphire Patient Payments
CategoryPatient Payments / Reimbursement Software
Description

Digital payment management solution for clinical trial participants, handling reimbursement tracking and receipt submission for sponsors, CROs, and research sites.

2Greenphire Travel
CategoryPatient Travel and Logistics Services
Description

Concierge travel and logistics coordination service for clinical trial participants, supporting travel arrangements, logistics, and participant convenience across global trials.

3Clinical Trial Technology Platform
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

Greenphire announced the acquisition of Clincierge, a provider of concierge travel and logistics support for clinical trial participants. The acquisition was completed on February 1, 2024, and was designed to enhance clinical trial support services by integrating patient care and technology. The deal aimed to improve participant experience, streamline trial processes, and expand service offerings for pharmaceutical companies and CROs globally.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Adjacent life sciences clinical content and process management offerings from Veeva that, while not direct DCT rivals, share the same enterprise pharma buyer and increasingly overlap with the broader unified clinical platform.

TypeBroad incumbent
Description

Broad life-sciences cloud incumbent serving pharmaceutical sponsors with overlapping capabilities in clinical operations, regulatory, and quality, alongside its core CRM/commercial offerings — competing with Suvoda/Greenphire on enterprise clinical platforms.

TypeEmerging player
Description

Life sciences technology vendor with clinical trial, safety, and regulatory platforms (including its LifeSphere CTMS/EDC/eCOA suite) — competing with Greenphire/Suvoda in mid-market and enterprise pharma.

TypeDirect peer
Description

Direct competitor in RTSM/IRT, eCOA, eConsent, and clinical trial technology platforms serving the same pharmaceutical sponsor and CRO buyers. Medidata is the long-standing market leader in this category, making it the most direct comparable.

TypeEmerging player
Description

Mid-market EDC and eClinical SaaS provider with eCOA and DCT offerings overlapping with Greenphire's patient-facing and data capture capabilities — particularly relevant for smaller biotech sponsors.

TypeEmerging player
Description

Cloud-based EDC and DCT platform serving academic and commercial sponsors with patient-centric trial capabilities — competes with Greenphire on unified patient experience and decentralized trial enablement.

TypeDirect peer
Description

Direct competitor formed from the merger of CRF Health and Bracket, specializing in eCOA, RTSM, patient engagement, and clinical supplies — closely comparable to Greenphire's patient payments, travel, and eCOA capabilities.

TypeBroad incumbent
Description

Large CRO and health data analytics firm with clinical trial technology offerings (eCOA, RTSM, decentralized trials) that compete head-to-head with Greenphire's unified DCT platform, often bundled with CRO services.

TypeDirect peer
Description

Direct competitor offering eCOA, RTSM, cardiac safety, and imaging solutions for clinical trials — overlapping with Greenphire/Suvoda on the patient-facing and randomization/supply side of the platform.

10Oracle Health Sciences
TypeBroad incumbent
Description

Broad incumbent offering EDC, eClinical, and clinical trial platforms (inheriting Phase Forward and Oracle Clinical) — competing with Greenphire/Suvoda on integrated trial technology for large pharma.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Greenphire

Clinical Trial Technology Softwaregreenphire.com

Greenphire provides patient payment and travel logistics technology for clinical trials, serving pharmaceutical sponsors, CROs, and research sites globally. Following its 2025 merger with Suvoda, it operates within a unified clinical trial technology platform spanning RTSM, eCOA, patient apps, and AI-enabled workflows.

What Greenphire does

Greenphire, founded in 2007 and headquartered near Philadelphia, Pennsylvania, built its business around clinical trial patient payments and travel logistics for pharmaceutical sponsors, contract research organizations (CROs), and clinical trial research sites. In February 2024, Greenphire acquired Clincierge to extend its concierge travel and patient support capabilities, and in 2025 the company merged with Suvoda to form a unified clinical trial technology platform. Following the merger, Greenphire Patient Payments and Greenphire Travel continue as branded product lines within the Suvoda platform, which now spans interactive response technology (RTSM/IRT), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), scheduling, site payments, and budgeting and benchmarking. The combined platform reports 6,000+ trials conducted across 115+ countries and a 34% share of trials that received FDA approval since 2024, with roughly 65% of trials concentrated in oncology, rare disease, and CNS indications.

The technology stack follows a platform-plus-modules architecture centered on RTSM/IRT, augmented by eCOA, eConsent, site payments, and budgeting modules. Recent investment has focused on AI: Sofia, an AI assistant deployed within the IRT platform to reduce administrative burden on study teams, and an agentic RTSM capability that the company positions as enabling deployment from kickoff to user acceptance testing in as little as two weeks. A unified patient-facing mobile application consolidates scheduling, questionnaires, travel details, receipt submission, and reimbursement tracking into a single interface, addressing a well-documented fragmentation problem in trial participant experience. The technology is backed by five granted platform architecture patents and has been recognized externally, including a consecutive-year Leader designation in Everest Group's 2025 RTSM PEAK Matrix and a 2026 MedTech Breakthrough award for the Patient App.

Greenphire operates an enterprise SaaS business model: revenue is generated through multi-year subscription licensing of the platform and its modules to pharmaceutical sponsors and CROs, with quote-based pricing initiated via a 'Request a Demo' engagement model. Distribution is exclusively direct enterprise field sales, supported by a content-led demand generation funnel (blog, The ClinTech Podcast, webinars, case studies, industry events) and a dedicated CRO partnership program. The company has no public pricing and no self-serve channel, consistent with regulated, mission-critical enterprise software economics in life sciences.

Greenphire firmographics

Firmographics
Name
Greenphire
Legal name
Greenphire LLC
Website
https://greenphire.com
Company type
Private
Founded year
2008
Operating status
Acquired
Headcount range
101–250 employees
Short description
Greenphire provides patient payment and travel logistics technology for clinical trials, serving pharmaceutical sponsors, CROs, and research sites globally. Following its 2025 merger with Suvoda, it operates within a unified clinical trial technology platform spanning RTSM, eCOA, patient apps, and AI-enabled workflows.
Ownership category
akta.pro rank

Greenphire industry classification

Industry
Product category
Clinical Trial Technology Software
NAICS
Computer Systems Design and Related Services (5415), Computer Systems Design Services (541512), Other Computer Related Services (541519), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical trial software
  • Patient payment solutions
  • Clinical trial travel
  • RTSM IRT platforms
  • ECOA eConsent

Where Greenphire is headquartered

Location

Headquarters

HQ city
King Of Prussia
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Greenphire business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise SaaS Platform Subscriptions: Subscription-based licensing of the clinical trial technology platform (RTSM/IRT, eCOA, eConsent, patient payments, travel, scheduling, site payments) to pharmaceutical sponsors and CROs. Enterprise agreements with pharmaceutical companies and CROs, consistent with multi-year contractual subscriptions.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise subscription pricing for pharmaceutical sponsors and CROs

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Greenphire product offering

Product offering

Core offering

Greenphire provides a clinical trial technology platform focused on patient payments, reimbursement management, and concierge travel and logistics support for clinical trial participants. Following its 2025 merger with Suvoda, the offering is delivered as part of a unified platform covering RTSM/IRT, eCOA, eConsent, patient payments, patient travel, scheduling, and site payments sold via enterprise SaaS subscriptions to pharmaceutical sponsors and CROs.

Product overview

Greenphire operates as part of the unified Suvoda clinical trial technology platform following the 2025 merger. The platform follows a platform-plus-modules architecture centered on RTSM (Interactive Response Technology) as the core product, augmented by eCOA and eConsent modules for data collection and compliance. Patient-facing solutions include the Greenphire Patient Payments and Greenphire Patient Travel products (acquired brands now integrated into the platform), alongside a unified Patient App that consolidates scheduling, questionnaires, travel details, and payment management. Supporting modules cover Site Payments and Budgeting & Benchmarking. The platform serves pharmaceutical sponsors and CROs across 115+ countries, with over 6,000 trials conducted including 65% in oncology, rare disease, and CNS.

Differentiator

Problem solved

Functional benefit

Brands

  • Greenphire Patient Payments: Patient payment solution for clinical trials
  • Greenphire Travel

Products and services

  • Greenphire Patient Payments Digital payment management solution for clinical trial participants, handling reimbursement tracking and receipt submission for sponsors, CROs, and research sites.
  • Greenphire Travel Concierge travel and logistics coordination service for clinical trial participants, supporting travel arrangements, logistics, and participant convenience across global trials.
  • Clinical Trial Technology Platform

Quantifiable outcome

  • 6,000+ clinical trials conducted on the platform, with 65% in oncology, rare disease, and CNS
  • +4 more outcomes

Companies that use Greenphire

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Greenphire technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature10 records

Greenphire partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ClinciergecoreStrategic or Co-development Partner · 1 February 2024Greenphire announced the acquisition of Clincierge, a provider of concierge travel and logistics support for clinical trial participants. The acquisition was completed on February 1, 2024, and was designed to enhance clinical trial support services by integrating patient care and technology. The deal aimed to improve participant experience, streamline trial processes, and expand service offerings for pharmaceutical companies and CROs globally.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Greenphire competitors and assessment

Company assessment

Others

  • Veeva Vault CTMS / eTMF: Adjacent life sciences clinical content and process management offerings from Veeva that, while not direct DCT rivals, share the same enterprise pharma buyer and increasingly overlap with the broader unified clinical platform.

Broad incumbents

  • Veeva Systems: Broad life-sciences cloud incumbent serving pharmaceutical sponsors with overlapping capabilities in clinical operations, regulatory, and quality, alongside its core CRM/commercial offerings — competing with Suvoda/Greenphire on enterprise clinical platforms.
  • IQVIA: Large CRO and health data analytics firm with clinical trial technology offerings (eCOA, RTSM, decentralized trials) that compete head-to-head with Greenphire's unified DCT platform, often bundled with CRO services.
  • Oracle Health Sciences: Broad incumbent offering EDC, eClinical, and clinical trial platforms (inheriting Phase Forward and Oracle Clinical) — competing with Greenphire/Suvoda on integrated trial technology for large pharma.

Emerging players

  • ArisGlobal: Life sciences technology vendor with clinical trial, safety, and regulatory platforms (including its LifeSphere CTMS/EDC/eCOA suite) — competing with Greenphire/Suvoda in mid-market and enterprise pharma.
  • Medrio: Mid-market EDC and eClinical SaaS provider with eCOA and DCT offerings overlapping with Greenphire's patient-facing and data capture capabilities — particularly relevant for smaller biotech sponsors.
  • Castor: Cloud-based EDC and DCT platform serving academic and commercial sponsors with patient-centric trial capabilities — competes with Greenphire on unified patient experience and decentralized trial enablement.

Direct peers

  • Medidata (Dassault Systèmes): Direct competitor in RTSM/IRT, eCOA, eConsent, and clinical trial technology platforms serving the same pharmaceutical sponsor and CRO buyers. Medidata is the long-standing market leader in this category, making it the most direct comparable.
  • Signant Health: Direct competitor formed from the merger of CRF Health and Bracket, specializing in eCOA, RTSM, patient engagement, and clinical supplies — closely comparable to Greenphire's patient payments, travel, and eCOA capabilities.
  • Clario: Direct competitor offering eCOA, RTSM, cardiac safety, and imaging solutions for clinical trials — overlapping with Greenphire/Suvoda on the patient-facing and randomization/supply side of the platform.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Greenphire social profiles

Digital presence

Greenphire financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Greenphire leadership team

Management profile

Number of profiles

Profiles5 records

Greenphire subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Greenphire funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Greenphire M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Greenphire

What does Greenphire do?

Greenphire provides a clinical trial technology platform focused on patient payments, reimbursement management, and concierge travel and logistics support for clinical trial participants. Following its 2025 merger with Suvoda, the offering is delivered as part of a unified platform covering RTSM/IRT, eCOA, eConsent, patient payments, patient travel, scheduling, and site payments sold via enterprise SaaS subscriptions to pharmaceutical sponsors and CROs.

Is Greenphire a public or private company?

Greenphire is a private company. It is classified as corporate owned and is currently acquired.

When was Greenphire founded?

Greenphire was founded in 2008. It employs 101 to 250 people.

Where is Greenphire based?

Greenphire is headquartered in King Of Prussia, United States, in the North America region.

How does Greenphire make money?

One revenue line is on record: enterprise SaaS Platform Subscriptions.

Who are Greenphire's main competitors?

Veeva Vault CTMS / eTMF is listed as an others. Broad incumbents are Veeva Systems, IQVIA and Oracle Health Sciences. Emerging players are ArisGlobal, Medrio and Castor. Direct peers are Medidata (Dassault Systèmes), Signant Health and Clario.

Does Greenphire have an API?

No public API is recorded for Greenphire.

What industry is Greenphire in?

Greenphire's product category is Clinical Trial Technology Software. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5415 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACSuvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operationsSuvoda announced a new platform release unifying its Suvoda and Greenphire products, adding AI and new functionality. The release aims to reduce manual work and give patients, sites, and sponsors more engagement choices. The company merged with Greenphire to create this integrated platform.EIN PresswireThe Top Clinical Trial Management Software According to the FeaturedCustomers Summer 2026 Customer Success ReportFeaturedCustomers released its Summer 2026 Clinical Trial Management Software Customer Success Report, ranking vendors by customer reference content. Market Leaders include Advarra, ArisGlobal, IQVIA, Medidata, and Veeva; Top Performers include Castor EDC, CRIO, and others; Rising Stars include CliniOps, Crucial Data Solutions, and Ennov. The report is based on over 2,000 verified customer references.PR NewswireSuvoda and Greenphire complete brand integration with unified website and social media presenceSuvoda LLC announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name following their merger announced in April 2025. The combined entity now offers a comprehensive clinical trial technology platform featuring eight integrated products, including IRT, eCOA, patient payments, travel services, eConsent, scheduling, and clinical finance solutions. The company plans to unify all solutions over the next several months with single sign-on, consistent user interface, and shared data layer, while continuing to support clinical trials across more than 95 countries.PR NewswireSuvoda and Greenphire complete brand integration with unified website and social media presenceSuvoda LLC announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name following their merger announced in April 2025. The combined company now offers a comprehensive clinical trial technology platform with eight integrated products covering IRT, eCOA, patient payments, travel, eConsent, scheduling, and clinical finance solutions. Going forward, the company will unify all solutions under a single sign-on, consistent user interface, and shared data layer to streamline operations for sponsors, sites, and patients.PR NewswireSuvoda et Greenphire achèvent l'intégration de leur marque en unifiant leur site web et leur présence sur les réseaux sociauxSuvoda LLC announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name following their merger announced in April 2025. The combined entity now offers a comprehensive clinical trial technology platform with eight integrated products, including IRT, eCOA, patient payments, and scheduling solutions. Suvoda, headquartered near Philadelphia with offices in the US, Spain, Romania, and Japan, supports over 2,000 clinical trials across more than 95 countries.PR NewswireSuvoda und Greenphire schließen die Markenintegration mit einer vereinheitlichten Website und Social-Media-Präsenz abSuvoda LLC announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name following a merger announced in April 2025. The integration creates a single clinical trial technology platform combining eight products—including IRT, eCOA, patient payments, travel services, eConsent, scheduling, and clinical finance solutions—to offer sponsors, CROs, study sites, and patients a unified experience. The company, headquartered near Philadelphia with offices in the US, Spain, Romania, and Japan, supports more than 2,000 studies across over 95 countries.PR NewswireSuvoda y Greenphire completan la integración de marca con un sitio web unificadoSuvoda LLC, a global clinical trial technology company, announced the completion of its brand integration with Greenphire, unifying both companies under the Suvoda name following their merger announced in April 2025. The combined entity now offers a comprehensive clinical trial technology platform with eight integrated products, including IRT, eCOA, eConsent, and the former Greenphire patient payment and travel solutions. The company will roll out unified branding across all products in the coming months, featuring a single sign-on, consistent user interface, and shared data layer for sponsors, sites, and patients.PR Newswire APACSuvoda and Greenphire Announce Completion of MergerSuvoda and Greenphire completed their merger, combining clinical trial technology and financial management services under the name Suvoda. Thoma Bravo is the lead strategic investor, with Bain Capital Tech Opportunities Fund and LLR Partners making minority investments. The unified platform aims to simplify workflows and provide expanded capabilities for sponsors, sites, and patients.SuvodaSuvoda and Greenphire Announce Completion of MergerSuvoda and Greenphire completed their merger, combining under the name Suvoda. The combined company, led by CEO Jagath Wanninayake, will offer unified clinical trial solutions, with Thoma Bravo as lead investor. The merger aims to streamline workflows and improve patient outcomes.PR NewswireSuvoda and Greenphire Announce Completion of MergerSuvoda and Greenphire completed their merger, bringing the two clinical trial technology companies under common ownership and management. The combined company, named Suvoda, will be led by CEO Jagath Wanninayake, with Thoma Bravo as lead strategic investor. The merger aims to provide a unified platform for clinical trial operations.